title: Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
abstract: Current results suggest that purged autologous bone marrow transplant may improve outcome for some subsets of high risk neuroblastoma, but the risk of relapse is still high.
authors.affiliation: Pediatric Clinical Oncology, University of California, San Francisco 94143-0106, USA.
authors.forename: K K
authors.initials: KK
authors.lastname: Matthay
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis; D001855:Bone Marrow Diseases / Q000139:chemically induced / Q000628:therapy; D016465:Bone Marrow Purging; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D016259:Genes, myc; D006801:Humans; D007223:Infant; D015993:Life Tables; D018365:Neoplasm, Residual; D009447:Neuroblastoma / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D010865:Pilot Projects; D016016:Proportional Hazards Models; D012306:Risk; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous; D016896:Treatment Outcome; D014916:Whole-Body Irradiation
chemical_list: D014408:Biomarkers, Tumor